C-met as a therapeutic target using ARQ 197 in renal cell carcinoma. Background: Systemic inflammation has been associated with increased tumor grade and disease progression in renal cell carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results